News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Agopyan Nadia
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| Agopyan Nadia (SVP, Regulatory Affairs) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 34,154 options to buy
@ $2.14, valued at
$73.1k
|
|
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Agopyan Nadia (VP, Regulatory Affairs) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.29, valued at
$131.6k
|
|
| 03/12/2020 |
4
| Agopyan Nadia (VP, Regulatory Affairs) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 7,300 options to buy
@ $2.12, valued at
$15.5k
Granted 32,700 options to buy
@ $2.12, valued at
$69.3k
|
|
| 08/19/2019 |
4
| Agopyan Nadia (VP, Regulatory Affairs) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $4.8, valued at
$960k
|
|
| 08/19/2019 |
3
| Agopyan Nadia (VP, Regulatory Affairs) has filed a Form 3 on Marker Therapeutics, Inc. |
|
|